Incyte
INCY
#1110
Rank
โ‚น1.808 T
Marketcap
โ‚น9,210
Share price
2.05%
Change (1 day)
45.17%
Change (1 year)

Revenue for Incyte (INCY)

Revenue in 2025 (TTM): โ‚น416.64 Billion

According to Incyte's latest financial reports the company's current revenue (TTM ) is โ‚น432.39 Billion. In 2024 the company made a revenue of โ‚น363.83 Billion an increase over the revenue in the year 2023 that were of โ‚น307.65 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Incyte from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น416.64 B14.51%
2024 โ‚น363.83 B18.26%
2023 โ‚น307.65 B9.52%
2022 โ‚น280.90 B26.38%
2021 โ‚น222.27 B13.97%
2020 โ‚น195.02 B26.69%
2019 โ‚น153.94 B16.99%
2018 โ‚น131.58 B34.15%
2017 โ‚น98.08 B30.54%
2016 โ‚น75.13 B50.01%
2015 โ‚น50.09 B54.52%
2014 โ‚น32.41 B47.83%
2013 โ‚น21.92 B34.82%
2012 โ‚น16.26 B225.51%
2011 โ‚น4.99 B-34.36%
2010 โ‚น7.61 B1670.7%
2009 โ‚น0.42 B128.16%
2008 โ‚น0.18 B-86.06%
2007 โ‚น1.35 B10.39%
2006 โ‚น1.22 B246.73%
2005 โ‚น0.35 B-24.29%
2004 โ‚น0.46 B-78.25%
2003 โ‚น2.14 B-56%
2002 โ‚น4.87 B-53.94%
2001 โ‚น10.57 B16.75%
2000 โ‚น9.06 B32.74%
1999 โ‚น6.82 B19.11%
1998 โ‚น5.73 B63.5%
1997 โ‚น3.50 B137.26%
1996 โ‚น1.47 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚น3.231 T 647.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น22.56 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น5.338 T 1,134.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.640 T 1,204.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
โ‚น16.47 B-96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚น35.77 B-91.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.064 T 1,071.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
โ‚น8.47 B-98.04%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚น6.80 B-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA